Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
BMJ Open|June 12, 2017
Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysisNick van Es, Grégoire Le Gal, Hans-Martin Otten, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2022
MT9, a natural peptide from black mamba venom antagonizes the muscarinic type 2 receptor and reverses the M2R-agonist-induced relaxation in rat and human arteriesJustyna Ciolek, Claude Zoukimian, Justine Dhot, et al.
Thrombosis and Haemostasis|June 24, 2019
Predictors for Residual Pulmonary Vascular Obstruction after Unprovoked Pulmonary Embolism: Implications for Clinical Practice-The PADIS-PE TrialLeela Raj, Philippe Robin, Raphael Le Mao, et al.
The American Journal of Medicine|April 26, 2020
Evaluation of Venous Thromboembolism Recurrence Scores in an Unprovoked Pulmonary Embolism Population: A Post-hoc Analysis of the PADIS-PE trialLeela Raj, Emilie Presles, Raphael Le Mao, et al.
The European Respiratory Journal|April 2, 2026
Comparison of Three Diagnostic Strategies for Suspicion of Pulmonary Embolism: Planar Ventilation-Perfusion Scan (V/Q), Computed Tomography Pulmonary Angiography (CTPA), and Single Photon Emission Computed Tomography Ventilation-Perfusion Scan (SPECT V/Q): a multicenter, non-inferiority randomised controlled trialRomain Le Pennec, Pierre-Yves Le Roux, Philippe Robin, et al.
Journal of Thrombosis and Haemostasis : JTH|August 26, 2022
Frequency and predictors for chronic thromboembolic pulmonary hypertension after a first unprovoked pulmonary embolism: Results from PADIS studiesAlexandre Fauché, Emilie Presles, Olivier Sanchez, et al.
The European Respiratory Journal|January 6, 2018
Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trialCécile Tromeur, Olivier Sanchez, Emilie Presles, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 21, 2023
[18F]DCFPyL PET/CT versus [18F]fluoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross-over, comparative studyDaniela-Elena Oprea-Lager, Eric Gontier, Lina García-Cañamaque, et al.
Pageof 13